AR PHARMA

ar-pharma-logo

Develops therapeutic antibodies to specific patient populations with high unmet medical needs. Its pipeline includes a portfolio of immuno-modulators and antibodies that are used alone and in strategic combinations to create disease-specific therapies that induce, enhance, or suppress the body’s immune response.

#SimilarOrganizations #People #Website #More

AR PHARMA

Industry:
Biotechnology Pharmaceutical

Founded:
2015-01-01

Address:
Woburn, Massachusetts, United States

Country:
United States

Website Url:
http://www.arrx.net

Total Employee:
1+

Status:
Active

Contact:
(781)281-2201

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud OpenResty


Similar Organizations

not_available_image

Santaris Pharmaceuticals

A biopharmaceutical company.

Founder


rajah-menon_image

Rajah Menon

Official Site Inspections

http://www.arrx.net

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "AR Pharma" on Search Engine

AR Pharma - Crunchbase Company Profile & Funding

Details. Industries. Biotechnology. Pharmaceutical. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2015. Founders Rajah Menon. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Phone Number …See details»

AR Pharma Company Profile 2024: Valuation, Funding

Operator of a biotech company intended to help in the development of therapeutic antibodies. The company's novel therapeutics is an anti-idiotype antibody, targeting …See details»

AR Pharma - Products, Competitors, Financials, …

Overview & Products. Financials. Stage. Debt | Alive. Total Raised. $410K. Last Raised. $410K | 8 yrs ago. About AR Pharma. AR Pharma was founded based on a …See details»

ArPharMa – Armenia

ASSOCIATION OF MANUFACTURERS OF PHARMACEUTICALS OF R A. OVER 18 YEARS OF ACTIVITY. Dear visitor. Welcome to our official website “Association of Manufacturers of Pharmaceuticals” (ArPharMa) …See details»

AR Pharma - Company Profile - Tracxn

Mar 1, 2024 Founded Year. 2015. Location. Woburn, United States. Company Stage. Funding Raised. Latest Funding Round. $410K, Conventional Debt, Oct 05, 2016. …See details»

ABOUT US – ArPharMa

ABOUT US – ArPharMa. Drug manufacturers of the RA united into Medicine Producers and Importers Union of Armenia (MPI Union). MPI Union has contributed to the development …See details»

About Us – AR Pharma

Abdul Rahim Pharma Committed to Supporting Healthcare Since 2005 Established in 2005, Abdul Rahim Pharma is a leading supplier of medical products dedicated to improving …See details»

About Us - A&R PHARMA

A&R Pharma. We are an Italian pharmaceutical company working in the field of antiviral prevention. We respond to therapeutic needs that have not yet been met, through …See details»

The Realities of VR and AR in the Industry | PharmaVoice

Jun 1, 2019 Bayer Pharmaceuticals, for one, has found a solution, as have several other pharmaceutical companies by using augmented reality (AR) and virtual reality (VR) capabilities to provide experiential educational content.See details»

Chief Executive – AR Pharma

Dr. Adil Nadeem Introduction Mr. Adil Nadeem, is a Doctor by profession, CEO of Abdul Rahim Pharma, the President of Riser Foundation and Vice President of Gujranwala …See details»

“AZAD” COMPANY – ArPharMa

“AZAD” COMPANY – ArPharMa. “Azad Pharmaceuticals” company was founded in 2000 in Switzerland, and in 2004 began its activities in Armenia. The company cooperates with European, Chinese, Indian companies. …See details»

This week’s big story: Augmented reality in pharma …

Feb 2, 2022 The launch of the new platform is the latest indication that AR in the pharma sector is here to stay. How AR could transform pharma supply chains. Unlike the immersive experience offered by virtual reality, …See details»

About | ArnaPharma

Arna Pharma is a global pharmaceutical company dedicated to improving global healthcare through innovative research, development, and manufacturing of high-quality …See details»

About Us – AR Pharmaceutical

Since setting up, AR Pharmaceuticals has developed a strong reputation as a procurement specialist, distributor and supply chain manager in the wider healthcare industry. It has …See details»

AR Pharmaceutical – Pharma

AR Pharmaceuticals is a pharmaceutical and non-consumables product distribution company in Kenya that targets a range of clientele in the health sector. The primary …See details»

Alvogen

Alvogen is a privately owned US-based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products. Alvogen's companies include: Alvogen generic business Almatica brand products Almaject injectables Norwich …See details»

COVID Vaccine - www.arrx.org

Jan 31, 2022 COVID Vaccine. The FDA officially granted full approval to Moderna for its COVID-19 vaccine for use in Americans 18 years of age and older. The vaccine, now …See details»

Augmented Reality (AR) in Healthcare & Pharma - Rock Paper …

Aug 10, 2021 Augmented Reality (AR) in Healthcare & Pharma | Rock Paper Reality. Home. Insights. AR Use Cases. ... Augmented Reality in the Pharmaceutical Industry. 7 …See details»

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics – ARS Pharma

SAN DIEGO – November 8, 2022 – ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) (ARS or the Company), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced the closing of its merger with Silverback Therapeutics, Inc. ...See details»

argenx | Homepage - Reaching Patients Through Immunology …

At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, …See details»